The High-dose Influenza Vaccine (HD vaccine) is designed specifically for older adults aged 65 years and above. It contains four times the hemagglutinin (HA) antigen compared to the standard dose, offering superior protection against influenza. With over 202 million doses distributed and 10 years of experience, it has proven efficacy in reducing hospitalizations due to pneumonia, cardiorespiratory issues, and influenza.